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ABSTRACT
OBJECTIVE: To assess the validity of dengue fever reports and how they 
relate to the definition of case and severity.
METHODS: Diagnostic test assessment was conducted using cross-
sectional sampling from a universe of 13,873 patients treated during the fifth 
epidemiological period in health institutions from 11 Colombian departments 
in 2013. The test under analyses was the reporting to the National Public 
Health Surveillance System, and the reference standard was the review of 
histories identified by active institutional search. We reviewed all histories 
of patients diagnosed with dengue fever, as well as a random sample of 
patients with febrile syndromes. The specificity and sensitivity of reports were 
estimated for this purpose, considering the inverse of the probability of being 
selected for weighting. The concordance between reporting and the findings 
of the active institutional search was calculated using Kappa statistics.
RESULTS: We included 4,359 febrile patients, and 31.7% were classified 
as compatible with dengue fever (17 with severe dengue fever; 461 with 
dengue fever and warning signs; 904 with dengue fever and no warning 
signs). The global sensitivity of reports was 13.2% (95%CI 10.9;15.4) and 
specificity was 98.4% (95%CI 97.9;98.9). Sensitivity varied according to 
severity: 12.1% (95%CI 9.3;14.8) for patients presenting dengue fever with 
no warning signs; 14.5% (95%CI 10.6;18.4) for those presenting dengue 
fever with warning signs, and 40.0% (95%CI 9.6;70.4) for those with severe 
dengue fever. Concordance between reporting and the findings of the active 
institutional search resulted in a Kappa of 10.1%.
CONCLUSIONS: Low concordance was observed between reporting and 
the review of clinical histories, which was associated with the low reporting 
of dengue fever compatible cases, especially milder cases.
DESCRIPTORS: Dengue, epidemiology. Epidemics, statistics & 
numerical data. Disease Notification. Sensitivity and Specificity. 
Epidemiological Surveillance.
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Dengue fever is an arthropod-transmitted viral disease 
having the greatest epidemiological, social, and economic 
impact. It is an increasing threat to global public health.8,9 
Since the 1980s, the incidence of dengue fever has 
increased in America, with a mortality rate that has tripled 
every decade.5,17 Colombia is not unfamiliar with this situ-
ation and has a continuous epidemic, affecting the popula-
tion residing ≤ 2,200 meters above sea level.a
To determine the magnitude of the problem and to 
guide and evaluate public health interventions, a reli-
able surveillance system is required to allow valid esti-
mation of the damage caused by the disease, as well 
as the changing patterns of morbidity and mortality. 
However, previous studies have identified problems that 
may affect the notifications of dengue fever cases, thus 
RESUMEN
OBJETIVO: Evaluar la validez de la notificación de casos de dengue y su 
correspondencia con las definiciones de caso y de gravedad.
MÉTODOS: Evaluación de prueba diagnóstica con muestreo transversal a 
partir de un universo de 13.873 pacientes atendidos durante quinto periodo 
epidemiológico en instituciones de salud de 11 departamentos de Colombia, 
en 2013. La prueba en evaluación fue la notificación al Sistema Nacional 
de Vigilancia en Salud Pública y el estándar de referencia fue la revisión de 
historias identificadas mediante búsqueda activa institucional. Se revisó todas 
las historias de pacientes con diagnóstico de dengue y una muestra aleatoria 
de pacientes con síndromes febriles. Se estimó especificidad y sensibilidad de 
notificación ponderando por el inverso de la probabilidad de ser seleccionado. 
Se calculó la concordancia entre notificación y los hallazgos de la búsqueda 
activa institucional usando el estadístico Kappa.
RESULTADOS: Se incluyeron 4.359 pacientes febriles, 31,7% fueron 
clasificados compatibles con dengue (17 con dengue grave; 461 con dengue 
y signos de alarma; 904 con dengue sin signos de alarma). La sensibilidad 
global de la notificación fue 13,2% (IC95% 10,9;15,4) y la especificidad 
98,4% (IC95% 97,9;98,9). La sensibilidad varió de acuerdo con la gravedad: 
12,1% (IC95% 9,3;14,8) en pacientes con dengue sin signos de alarma; 14,5% 
(IC95% 10,6;18,4) en aquellos con dengue y signos de alarma y 40,0% (IC95% 
9,6;70,4) en aquellos con dengue grave. La concordancia entre la notificación 
y los hallazgos de la búsqueda activa institucional mostró Kappa de 10,1%.
CONCLUSIONES: Se observó baja concordancia entre la notificación y la 
revisión de historias clínicas, que estuvo asociada a baja notificación de los 
casos compatibles con dengue, especialmente aquellos menos graves.
DESCRIPTORES: Dengue, epidemiología. Epidemias, estadística & datos 
numéricos. Notificación de Enfermedad. Sensibilidad y Especificidad. 
Vigilancia Epidemiológica.
INTRODUCTION
compromising the validity of the information obtained 
by the system.3,11,12 The lack of consensus between clin-
ical and laboratory diagnosis,11,12 as well as the poor 
compliance to the severity classifications,3 has been 
particularly suggested.
The systematic assessment of activities regarding 
dengue fever surveillance is necessary. Therefore, the 
purpose of this study was to evaluate the validity of 
dengue fever case reporting and the relation to case 
definition and severity.
METHODS
Test diagnostic assessment was performed with 
cross-sectional sampling. The reporting to the Public 
a Instituto Nacional de Salud. Informe del evento dengue decimo periodo epidemiológico año 2013. Available from: http://www.ins.gov.co/
lineas-de-accion/Subdireccion-Vigilancia/Informe%20de%20Evento%20Epidemiolgico/DENGUE%202013.pdf
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Health Surveillance System (PHSS) was considered 
as the test under evaluation, and the classification of 
patients according to the criteria by the World Health 
Organization (WHO)20 was considered the test of refer-
ence (gold standard) by reviewing their medical records 
obtained by active institutional search (AIS). This type 
of search provided external data to the reports, as recom-
mended for the evaluation of surveillance systems.7
The study population was patients with acute febrile 
illness (AFI) of unknown origin who visited health 
institutions from 11 endemic cities of different 
Colombian states. Such cities were prioritized by the 
National Institutes of Health and the Ministry of Health 
and Welfare because they were in an outbreak situation 
since the first trimester of 2013. In every city, health 
institutions (primary units for data generation: UPGD) 
that regularly reported the highest number of dengue 
fever cases were selected.
The study population was represented by the AFI cases 
admitted to each institution during the fifth epidemio-
logical period (epidemiologic week, EW 17-20) who 
met the inclusion criteria: at least one diagnosis checked 
in the individual records service (RIPS), according to 
the International Statistical Classification of Diseases 
and Health Related Problems, tenth revision (ICD-
10) [“virosis” or unspecified viral infection (B349), 
unspecified fever (R509), relapsing fever (A689), 
Hemorrhagic fever with renal syndrome (A985), 
dengue fever (A90X) or dengue hemorrhagic fever 
(A91X)]; and diagnosis of acute illness characterized 
by fever lasting less than seven days.
In every city, all dengue fever diagnosed cases (A90X 
and A91X) were selected for the review, and a sample 
of approximately 400 medical histories among the total 
identified AFI cases (B349, R509, A689, and A985) was 
obtained by random simple sampling with proportional 
distribution to the number of medical appointments 
in every institution. The probability of inclusion was 
constant for the institutions within the same city, but 
it varied among different cities. In addition, the prob-
ability of inclusion was inversely proportional to the 
number of AFI cases reported by the total number of 
selected institutions.
The clinical history of each selected patient was 
reviewed, and the signs, symptoms, and CBC find-
ings were recorded using a standardized instrument, 
including the OMS criteria to define the severity.20 
The patients were organized in one of the following 
categories: dengue fever with no warning signs (WS) 
– acute febrile disease, < 7 days, with two or more 
of the manifestations (including headache, retro-
orbital pain, myalgia, arthralgia, rash, or exanthema); 
dengue fever with WS – patient with at least one of 
the abovementioned manifestations and any of the 
WS (including intense and continuous abdominal 
pain, persistent vomiting, drowsiness and/or irrita-
bility, postural hypotension, painful hepatomega-
lyia > 2 cm, decreased diuresis, temperature drop, 
mucous hemorrhage, abrupt drop in platelet count 
(< 100,000) associated with hemoconcentration); 
severe dengue fever – patient with some of the 
previous definitions and any of the complications 
{including severe plasma exudation, which leads to 
shock syndrome or fluid accumulation with respi-
ratory difficulty, such as pleural effusion, ascites, 
pericardial effusion, severe hemorrhaging, serious 
organ damage [including myocarditis, encephalitis, 
hepatitis (transaminases > 1,000), acalculous chole-
cystitis, acute kidney failure or damage to other vital 
organs]}; dengue fever mortality; and patients with 
no dengue fever (did not meet the criteria of the 
previous categories).
The definitions above20 are currently used for the 
surveillance of dengue fever in Colombia. The applica-
tion of this classification in the clinical records selected 
by AIS was considered to be the reference standard 
regardless of whether there was confirmation of infec-
tion by laboratory tests.
The patients included in this study, who were reported 
for dengue fever, were identified in the PHSS records; 
if they were reported, the severity groups were identi-
fied by reporting institutions. To link the databases, i.e., 
to identify the individuals reported to PHSS, the iden-
tification number was used (citizenship card for adults 
and the unique personal identification number (UPIN) 
for individuals under 18 years of age).
The study population was described according to 
demographic and clinical variables, and the distribu-
tion of its origin. The relation between the patterns of 
dengue fever case reports to PHSS and the classification 
obtained by reviewing medical records was evaluated.
Two approaches were considered:
a) Considering the review of histories identified by 
AIS and the reports to SIVIGILA as two different 
and independent ways of measuring the frequency 
of the illness and the classification of its severity, 
we measured the concordance between these two 
surveillance strategies by calculating the Kappa 
statistics. A perfect concordance would be observed 
if no patients classified as not infected with den-
gue fever were reported during AIS, and in addi-
tion, if all patients compatible with dengue fever 
were reported, following the same classification 
obtained by the review of clinical histories. The 
weighted value of Kappa was calculated, assign-
ing the value of 0.5 to the diagonals adjacent to the 
main value. Furthermore, the value of Kappa for 
the classification of the severity was estimated by 
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considering only the patients reported and included 
in one of the dengue fever categories during AIS.
b) The second approach followed a design of crite-
rion standard validation study. The classification of 
cases based on the review of clinical histories was 
considered as the reference standard; the specificity, 
sensitivity, and the positive and negative predicted 
values (PPV and NPV) of reporting to SIVIGILA 
were estimated. The reports of patients were consid-
ered to be valid if they met any of the dengue fever 
definitions, regardless of whether or not there was 
consensus on the classification of severity. The prob-
ability of being selected varied between cities and 
was higher for patients with diagnostics of dengue 
fever; therefore, weights were calculated using the 
inverse of probability of being selected. The global 
estimation of validity indicators was performed and 
95% confidence intervals (95%CI) were calculated.
The relation between the severity of dengue fever 
and the probability of being reported was evaluated 
as secondary analysis. Reporting was considered the 
dependent variable, whereas severity ratings during 
the AIS were taken as the independent variable. The 
reference category was the group with no dengue fever. 
The hypothesis that the notification of dengue fever is 
influenced by the severity of the disease was evaluated. 
Prevalence ratios (PR) were used as a measure of asso-
ciation, and binomial regression was applied to estimate 
and to adjust for age and sex variables.
RESULTS
In total, 13,873 patients were identified with ICD-10-
compatible diagnostics, including 265 with diagnosis 
of dengue fever (A90X and A91X). From the patients 
with other diagnosis (n = 13,608), a sample with 
4,094 SFA patients was obtained. As a result, 4,359 
cases originating from 45 institutions from 11 terri-
torial entities (Table 1) were reviewed. When OMS 
criteria were applied, 2,977 patients were considered 
not infected with dengue fever; 904 were classified as 
having dengue fever with no WS; 461 were classified 
as having dengue fever with WS; and 17 were classi-
fied as having severe dengue fever.
The average age of the patients classified as having 
dengue fever (including all categories of severity) 
was 27.1 years (mean of 18 years). Of these, 42.0% 
presented in patients < 14 years old and 2.4% in patients 
< 1 year old. A percentage of 40.4% corresponded to 
women and 59.6% to men. Among the patients, 63.2% 
scheduled an appointment within the first three days of 
the illness; 31.1% between the fourth and seventh day; 
and 5.7% had no information regarding the number of 
days after fever onset.
The application of OMS criteria revealed 1,382 patients 
compatible with dengue fever; among them, 210 were 
reported to SIGIVILA, including 135 who were reported 
as having dengue fever with no WS, 61 as having dengue 
with WS, and 14 as having severe dengue fever (Table 2).
Table 1. Distribution of the study population and sample selected by territorial entity. Colombia, 2013.
Territorial
entitya
Number of
selected
institutions
ICD-10 Diagnosisb
AFI Sample
Revised histories 
(Dengue fever + AFI 
Sample)
 
Dengue fever
(A90X, A91X)
Others AFI (B349, 
R509, A689, A985)
Bucaramanga 7 58 1,524 419 477
Magdalena 6 6 1,238 434 440
Cali 5 47 1,007 425 472
Girardot 5 44 1,064 382 426
Villavicencio 5 0 679 325 325
Neiva 4 2 4,652 472 474
Cartagena 4 0 888 332 332
Valledupar 3 2 1,516 325 327
Ibagué 3 0 248 244 244
Cúcuta 2 3 386 339 342
Riohacha 1 103 406 397 500
Total 45 265 13,608 4.094 4,359
a Corresponds to the city where the information was obtained, except for the department of Magdalena (which obtained 
information of 4 municipalities).
b Search of medical code records of the tenth version of the International Classification of Diseases (ICD-10) was used in 
diagnostics: dengue fever (A90X); hemorrhagic dengue fever (A91X); viral infection, unspecified (B349); fever, unspecified 
(R509), relapsing fever, unspecified (A689), hemorrhagic fever with renal syndrome (A985).
903Rev Saúde Pública 2014;48(6):899-905
Although there was a global consensus of 69.0%, this 
was attributed to the high number of unreported non-
dengue cases (Table 2), which represented 67.0% of 
all patients. This corresponded to Kappa statistics of 
10.0% and weighted Kappa reaching 11.5%. On the 
other hand, we observed a concordance percentage 
of 57.9% and a Kappa value of 20.9% regarding the 
severity classification of the reported patients.
High specificity of 98.4% (95%CI 97.9;98.9) was 
observed when estimating the indicators of validity. 
The predictive values were approximately 75.0% 
(PPV = 74.9%; 95%CI 68.1;81.6; NPV = 75.9%; 95%CI 
74.3;77.4). The global report sensitivity was 13.2% 
(95%CI 10.9;5.4) with values of 12.0% (95%CI 9.3;14.8) 
for dengue fever with no WS, 14,5% (95%CI 10,6;18,4) 
for dengue fever with WS, and 40.0% (95%CI 9.6;70.4) 
for severe dengue fever.
The probability of being reported was multiplied by 7.5 
(95%CI 5.2;11.1) for the patient who met the criteria 
for dengue fever with no WS, by 9.1 (95%CI 6.1;13.6) 
for the patient who met the criteria for dengue fever 
with WS, and by 25.1 (95%CI 11.9;52.9) for the patient 
who met the criteria for severe dengue fever, when 
compared with patients without dengue. This ratio was 
maintained after the adjustment to variables of age and 
gender (Figure).
DISCUSSION
Dengue has become a growing public health problem 
that exceeds the capabilities of control within endemic 
countries. This study was conducted in an outbreak 
situation in different territorial entities of an endemic 
country where more than 80.0% of the population is at 
risk of contracting the infection.a
The main finding of this study is the low concor-
dance between reporting to the surveillance system 
and the systematic application of the clinical defi-
nitions suggested by OMS to identify and classify 
dengue fever. If we consider these internationally 
adopted definitions as a reference standard, the low 
concordance would be explained by the low sensi-
tivity to reporting, with sub-registration > 85.0% 
of dengue fever compatible cases.
This problem has already been reported in literature 
for different scenarios.4,6,10,15,16,18,19 A study conducted 
at Ibagué, Colombia, reported a sensitivity of 11.0%, 
a value approaching the estimation by this study 
(13.2%), for reporting suspicious dengue fever cases 
received by the emergency services during the second 
dengue fever epidemic that occurred between 1995 
and 1997.3 However, the sensitivity varies broadly 
between endemic countries. To compare them, we 
used the expansion factor (EF), which is the inverse of 
sensitivity and corresponds to the value by which the 
reported cases should be multiplied to obtain a better 
estimation of such cases.19
For Colombia, the EF would be approximately 7.6 
(inverse of 13.2%), according to the results of this 
study. In other Latin American countries, wide vari-
ations are reported. In Brazil, the EF is estimated 
as 1.6 for hospitalized cases, a value that contrasts 
the EF of > 14 estimated for Nicaragua in the last 
decade.18 The EF has also been reported to vary 
according to the severity of the disease, and its 
value is found to be higher for milder cases.6,18 This 
is in accordance with the observations of this study, 
where the EF values were 2.5, 6.9, and 8.3, for the 
groups with severe dengue fever, dengue fever with 
no WS, and dengue fever with WS, respectively.
In addition to considering reporting problems, the 
low concordance could put in question the useful-
ness of the case definitions and severity proposed by 
the OMS. The severity classification was recently 
revised in an attempt to make it more functional 
and a representative of the need for specialized 
support.20 As a result, OMS integrated the concept 
of severe dengue, which is specific to conditions 
that require procedures of high complexity, such as 
Table 2. Distribution of patients with acute febrile illness according to World Health Organization20 criteria and notification to 
Public Health Surveillance System. Colombia, 2013.
Notification status
Classification of patients using WHO criteria
Total 
No dengue fever Dengue without WS Dengue fever with WS Severe Dengue fever 
Not notified 2,926a 817 397 9 4,149
Dengue fever without WS 32 64a 37 2 135
Dengue fever with WS 18 21 22a 0 61
Severe Dengue fever 1 2 5 6a 14
Total 2,977 904 461 17 4,359
WS: Warning signs
a Percentage of overall agreement: 69.2% (Expected: 65.8%); Kappa: 10.06% (Standard Error: 0.72%); Weighted Kappa: 
11.5% (Standard Error: 0.76%).
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resuscitation, transfusions, inotropic and respira-
tory support, or specific treatment for organ failure.2
This severity definition represents a small proportion 
of patients with dengue fever. This implies a restric-
tion of its applicability, given that the majority of 
dengue fever infections do not require hospitalization 
or such interventions.1,14 Consequently, the category 
for severe dengue fever seems a little insensitive in the 
characterization of disease damage in terms of total 
hospitalizations and socioeconomic losses caused by 
the disability.
Case definitions, with or without WS, define all febrile 
events as dengue fever suspects, with symptoms that are 
very unspecific, as they are common in other prevailing 
tropical diseases. Therefore, the case definitions have 
been widely criticized for their inability to discriminate 
between dengue fever and other SFA cases.11 These 
public health surveillance tools have important limi-
tations that can negatively affect their acceptance by 
health professionals who must apply them.
There are other obstacles to disease reporting, including 
difficulties in clinical diagnosis, administrative factors, 
and possible negative expectations regarding the 
reports. Previous studies have reported difficulties 
in identifying dengue fever in the first appointment, 
usually when complications have not yet arised.11,12
Furthermore, there are factors within the institutions 
that limit the access to health services and increase 
condition of social exclusion in populations without 
medical insurance. This happens regardless of the 
regulatory effects, for they favor their assistance 
within the General Health Social Security System 
(GHSSS). Because inequality is evidently caused 
by bureaucratic procedures, there is limited inter- 
and intrasectorial coordination, lack of resources to 
health service providers, and the excess of formali-
ties for the assistance.13
The administrative factors, including the lack of 
time of professionals to fill-in forms, can reduce 
case reporting. Furthermore, it is plausible that 
health professionals have poor expectations 
regarding the reports. This is caused by the fact that 
only a small proportion of reported patients undergo 
laboratory tests and the incidence of serious compli-
cations is relatively small considering the volume 
of SFA patients that should be reported.
Reporting could be focused to the more serious patients 
who spend more time in inner hospital environment 
assessed by a greater number of health professionals, 
and who develop manifestations typically attributed to 
dengue fever. This could lead to the delayed identifica-
tion of cases with potentially fatal complications, thus 
preventing the implementation of preventive measures 
at the early febrile stage.
The main limitation of this study is the retrospective 
collection of information. Therefore, it could possibly 
not identify relevant information for the classification of 
patients. In addition, this research does not include labo-
ratory studies that allow the estimation of consensus 
between the corroborative evidence and the clinical 
perception represented by the clinical histories and in 
the ultimate report.
However, the identification of additional clinical 
data would probably evidence more unreported 
dengue fever-compatible patients. In addition, the 
absence of laboratory evidence does not invali-
date the findings of poor consensus found between 
reporting and the systematic application of interna-
tionally suggested clinical definitions. This finding 
reveals an important barrier for the estimation of 
disease damage and the assessment of interven-
tions, individual and community based, directed at 
reducing the damage caused by this priority disease.
The results of this study, which had a considerable 
number of fever cases from different regions of an 
endemic country, evidenced the lack of consensus 
between the reporting of dengue cases and the 
systematic application of the definitions proposed 
by the WHO. This could be associated with the low 
acceptance of these reference definitions, with diffi-
culty in the diagnosis or with negative reactions 
toward public health surveillance processes. It is 
necessary to develop easily applicable strategies to 
identify and notify dengue fever cases, as well as 
to improve the surveillance system and support the 
enhancement of prevention and control measures.
Den-SA: Dengue fever with warning signs; Den-Grave: 
Severe Dengue fever
Error bars show the confidence intervals of 95%, which 
were truncated at 30 for the group of severe dengue fever.
Figure. Relationship between dengue fever severity and the 
probability of being reported. Colombia, 2013.
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